在老年人中使用静脉铁
Hsin-Hui Chen1, Katie E Cardone1
1Albany College of Pharmacy and Health Sciences, Albany, New York.
Journal of gerontological nursing
|December 2, 2025
概括
静脉注射 (IV) 铁是一种安全有效的治疗老年人缺铁的方法,当口服铁不足时. 它迅速补充铁库,改善健康和生活质量,风险最小.
科学领域:
- 老年病的医生 老年病的医生
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 铁缺乏症 (ID) 在老年人中很普遍,与健康状况不佳有关.
- 在这个人群中,口服铁的耐受性或吸收性往往很差.
- 静脉注射 (IV) 铁为老年人管理ID提供了替代方案.
研究的目的:
- 在老年人中审查IV铁疗法的疗效和安全性.
- 讨论给老年患者注射静脉铁的实际考虑.
主要方法:
- 对老年人IV铁研究的文献综述.
- 对疗效,安全性和耐受性数据的分析.
- 考虑临床情景和并发症.
主要成果:
- 静脉注射铁有效地恢复铁水平,改善血红蛋白,功能和生活质量.
- 它减少了对输血的需要.
- 常见的并发症,如CKD和心力衰竭,往往表明IV铁使用.
- 副作用很少见,过敏反应和输液反应是最常见的.
结论:
- 输液铁是一种安全有效的治疗老年人缺铁.
- 当口服铁不适合时,它提供快速可靠的铁补充.
- 考虑到患者的并发病和风险的个性化治疗对于最佳结果至关重要.
相关概念视频
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
221
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
221
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
183
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
216
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
216
Renal Failure: Dose Adjustments
407
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
407


